No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
299 |
4. Check minimum number of eventsNone |
299 |
5. Include endpointsNone |
299 |
6. Filter based on genotype QC (FinnGen only) |
299 |
Control definitions (FinnGen only)
- Control exclude
- N14_GLOMERULAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N00-N08
- Name in latin
- Haematuria recidiva et persistens
Similar endpoints
↥List of similar endpoints to
Recurrent and persistent haematuria
based on the number of shared cases.
Similar with more cases:
- Glomerulonephritis
- Glomerular diseases
- Genitourinary diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2501 | 1150 | 1325 |
| Only index persons | 2128 | 1044 | 1084 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.03 | 0.04 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 52.05 | 43.41 | 59.18 |
| Only index persons | 48.62 | 41.87 | 55.11 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 299 | 140 | 159 |
| Unadjusted period prevalence (%) | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | 51.75 | 43.14 | 59.34 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 274
- Matched controls
- 2739
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N02.9
ICD-10 Finland
Recurrent and persistent haematuria, unspecified
+∞
152.8
132
*
R31
ICD-10 Finland
Unspecified haematuria
14.4
65.0
122
144
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
+∞
47.3
44
*
N02
ICD-10 Finland
Recurrent and persistent haematuria
+∞
31.9
30
*
UKC02
NOMESCO Finland
Cystoscopy
5.8
30.6
103
259
N02.0
ICD-10 Finland
Recurrent and persistent haematuria, minor glomerular abnormality
+∞
29.7
28
*
N02.8
ICD-10 Finland
Recurrent and persistent haematuria, other
+∞
29.7
28
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
29.9
24.2
32
12
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
+∞
22.2
21
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
87.4
22.0
24
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
29.3
21.8
29
11
A11CC03
ATC
alfacalcidol; systemic
23.9
21.3
30
14
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
+∞
21.1
20
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
18.9
21.1
32
19
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
52.4
20.5
24
5
N18.8
ICD-10 Finland
Other chronic renal failure
21.4
20.0
29
15
B03XA01
ATC
erythropoietin; parenteral
71.5
18.0
20
*
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
+∞
17.9
17
*
A12AA04
ATC
calcium carbonate; oral
45.3
17.5
21
5
N02.2
ICD-10 Finland
Recurrent and persistent haematuria, diffuse membranous glomerulonephritis
+∞
15.8
15
*
N02.1
ICD-10 Finland
Recurrent and persistent haematuria, focal and segmental glomerular lesions
+∞
15.8
15
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.9
15.7
40
66
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.7
15.3
36
53
Z94.0
ICD-10 Finland
Kidney transplant status
33.8
15.0
19
6
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
60.1
15.0
17
*
N02.3
ICD-10 Finland
Recurrent and persistent haematuria, diffuse mesangial proliferative glomerulonephritis
+∞
14.7
14
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
158.0
14.6
15
*
L04AA06
ATC
mycophenolic acid; systemic
20.5
14.5
21
11
137
Kela drug reimbursment
Uraemia requiring dialysis
79.2
13.7
15
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
22.5
12.2
17
8
R80
ICD-10 Finland
Isolated proteinuria
22.5
12.2
17
8
B03XA02
ATC
darbepoetin alfa; parenteral
21.1
11.3
16
8
L04AD01
ATC
ciclosporin; systemic
21.1
11.3
16
8
127
Kela drug reimbursment
Transplant complication
18.8
10.9
16
9
N18.0
ICD-10 Finland
End-stage renal disease
29.4
10.8
14
5
N02.4
ICD-10 Finland
Recurrent and persistent haematuria, diffuse endocapillary proliferative glomerulonephritis
+∞
10.5
10
*
N02BE
ICD-10 Finland
NA
+∞
10.5
10
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
10.4
52
174
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
41.7
10.0
12
*
B05DB
ATC
Hypertonic solutions
57.0
9.7
11
*
B05DA
ATC
Isotonic solutions
57.0
9.7
11
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
103.4
9.5
10
*
TK800
NOMESCO Finland
Hemodialysis
11.2
9.4
17
16
J01MA02
ATC
ciprofloxacin; systemic
2.3
9.4
124
729
Z49.2
ICD-10 Finland
Other dialysis
38.0
9.1
11
*
C03CA01
ATC
furosemide; systemic
2.4
9.0
94
490
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.2
8.8
49
176
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
51.7
8.7
10
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
8.7
28
63
205
Kela drug reimbursment
Chronic hypertension
2.4
8.6
86
436
V03AE01
ATC
polystyrene sulfonate; oral
20.8
8.5
12
6
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
+∞
8.4
8
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
34.4
8.1
10
*
L04AA01
ATC
[U] ciclosporin; systemic
13.6
8.0
13
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.2
7.4
88
482
C09AA02
ATC
enalapril; systemic
2.5
7.4
65
308
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.9
7.3
45
174
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
30.9
7.2
9
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
20.7
7.2
10
5
C08CA01
ATC
amlodipine; oral
2.1
7.1
102
604
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
8.6
6.9
14
17
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
6.9
25
64
UKB02
NOMESCO Finland
Retrograde ureteroscopy
17.2
6.8
10
6
R60.0
ICD-10 Finland
Localized oedema
3.1
6.7
35
122
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
6.5
77
417
R33
ICD-10 Finland
Retention of urine
3.3
6.5
32
107
K65.0
ICD-10 Finland
Acute peritonitis
14.8
6.4
10
7
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.4
116
748
R50.9
ICD-10 Finland
Fever, unspecified
2.5
6.4
50
222
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
6.4
102
627
N30.0
ICD-10 Finland
Acute cystitis
2.7
6.3
44
183
J01DB01
ATC
cefalexin; oral
2.1
6.3
221
1811
M05BA04
ATC
alendronic acid; oral
3.4
6.3
29
92
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
+∞
6.3
6
*
N03.2
ICD-10 Finland
Chronic nephritic syndrome, diffuse membranous glomerulonephritis
+∞
6.3
6
*
N04.2
ICD-10 Finland
Nephrotic syndrome, diffuse membranous glomerulonephritis
+∞
6.3
6
*
A02BC02
ATC
pantoprazole; systemic
1.9
6.2
170
1265
C09CA01
ATC
losartan; oral
2.2
6.0
67
353
N02BE01
ATC
paracetamol; systemic, rectal
2.1
6.0
224
1859
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
176
913
3.26
22.21
11.4
4.4
34.4
35.7
g/l
2.08
168
861
20
15
14.22
21.29
2.1
3.7
—
—
—
0
0
159
807
3.07
20.32
9.9
3.0
—
—
—
0
0
65
189
4.12
20.30
12.4
3.1
1.5
2.0
mmol/l
0.46
54
139
82
286
3.57
19.63
5.4
2.0
23.0
23.4
%
0.08
72
248
41
84
5.50
19.62
12.9
3.0
23.5
24.1
mmol/l
0.63
35
76
130
606
3.03
19.08
9.4
3.7
33.0
10.0
mg/mmol
2.69
108
385
20
19
11.21
18.41
1.1
1.1
—
—
—
0
0
182
1057
2.84
17.17
17.1
6.3
1.2
1.2
mmol/l
0.15
161
894
26
39
7.21
16.86
7.8
4.9
184.2
362.0
iu/ml
—
5
5
169
967
2.72
16.06
14.3
5.6
1.2
1.2
mmol/l
0.09
157
873
118
579
2.71
15.03
3.9
2.6
3308.4
7723.9
umol/l
0.61
111
505
183
1129
2.60
14.32
7.9
3.4
0.0
0.0
estimate
0.00
33
220
21
30
7.45
14.17
5.4
4.6
—
5455.0
—
0
5
185
1156
2.57
13.95
7.9
3.4
0.0
0.0
estimate
0.00
33
207
13
0
+∞
13.64
1.3
0.0
—
—
—
0
0
26
49
5.72
13.50
1.8
1.2
—
—
—
0
0
132
718
2.50
13.24
5.5
3.1
2.3
2.3
mmol/l
1.87
120
630
181
1137
2.50
13.23
10.6
4.7
0.0
0.0
estimate
0.50
33
221
118
618
2.50
12.74
8.8
3.0
0.3
0.4
e6/l
0.64
93
460
25
51
5.26
11.91
1.4
1.3
—
—
—
0
0
213
1484
2.51
11.80
10.4
4.2
183.3
275.5
e6/l
—
10
27
104
532
2.46
11.64
2.4
2.0
2.8
3.0
mg/l
0.57
93
450
11
0
+∞
11.53
5.9
0.0
—
—
—
0
0
60
238
2.90
11.13
7.3
8.8
0.8
1.2
mmol/l
0.21
44
189
26
60
4.65
10.74
1.8
3.2
—
1.3
—
0
8
26
61
4.57
10.53
1.9
3.3
47.2
149.1
mg/l
0.51
18
51
26
61
4.57
10.53
1.9
3.3
35.0
31.2
mg/l
0.22
18
51
160
1018
2.23
10.47
4.7
2.5
141.2
117.7
ug/l
0.78
148
939
39
130
3.30
9.68
4.3
3.2
2.1
1.4
mmol/l
0.42
27
99
75
369
2.38
8.86
6.1
2.7
1.9
1.0
e6/l
0.67
47
207
55
236
2.63
8.68
8.0
8.8
11.3
12.1
kpa
0.52
50
227
55
236
2.63
8.68
7.9
8.8
4.9
5.0
kpa
0.28
50
225
140
891
2.07
8.66
8.3
3.5
—
—
—
0
0
139
889
2.05
8.42
3.3
2.1
70.2
74.9
nmol/l
1.48
133
791
60
277
2.46
8.11
10.1
6.6
103.8
104.3
mmol/l
0.38
55
272
71
355
2.31
8.02
6.5
2.9
1.9
2.4
e6/l
0.24
42
197
185
1337
2.01
7.70
16.1
9.5
4.4
4.1
e9/l
0.98
173
1179
224
1747
2.13
7.38
13.4
7.1
76.4
76.8
u/l
0.04
217
1628
34
125
2.94
7.14
7.7
5.1
23.9
24.7
mmol/l
0.60
34
125
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
62
3.75
7.01
3.8
2.3
0.3
0.3
u/ml
0.27
12
35
90
527
2.01
6.68
2.8
2.3
—
—
—
0
0
69
366
2.15
6.66
2.5
1.8
—
—
—
0
0
12
22
5.64
6.34
1.2
1.2
—
—
—
0
0
52
254
2.27
6.12
2.5
1.8
—
—
—
0
0
85
502
1.97
6.09
8.4
3.6
1.0
1.0
kg/l
0.51
16
72
177
1321
1.83
6.04
9.5
4.7
6.5
6.7
mmol/l
0.60
172
1224
36
150
2.59
5.98
1.9
1.5
—
—
—
0
0
69
385
2.03
5.77
2.0
1.6
1399.1
1201.7
nmol/l
0.71
54
288
38
168
2.45
5.58
3.6
2.6
49.8
69.6
ml/min/173m2
1.33
19
72
125
857
1.79
5.52
2.3
1.9
90.9
94.1
pmol/l
0.40
70
446
97
620
1.84
5.38
9.0
3.7
0.0
0.0
estimate
0.40
29
213
266
2314
2.35
5.30
33.3
13.6
21.3
23.5
mg/l
0.64
244
1819
156
1151
1.74
5.26
7.7
6.2
12.9
11.3
umol/l
0.39
156
1090
146
1059
1.74
5.22
5.9
4.1
—
—
—
0
0
84
519
1.86
5.16
1.7
1.5
16.5
20.8
nmol/l
2.77
79
444
8
6
13.65
5.10
1.0
1.0
—
—
—
0
0
49
253
2.12
5.01
2.5
1.8
—
—
—
0
0
18
57
3.30
4.85
1.3
1.2
—
—
—
0
0
98
662
1.71
4.36
2.7
2.2
133.8
348.8
u/l
1.21
93
636
43
224
2.07
4.29
5.3
3.4
—
—
—
0
0
20
73
2.86
4.28
1.6
2.6
—
—
—
0
0
64
388
1.83
4.10
6.6
3.3
4167.4
206.2
ng/l
0.48
47
292
109
768
1.66
4.10
4.1
2.9
29.7
32.9
u/l
0.46
104
728
11
28
4.04
4.01
1.1
1.1
—
—
—
0
0
69
437
1.75
3.81
2.0
1.7
400.2
439.7
pmol/l
0.56
61
380
21
84
2.61
3.80
1.6
1.2
—
—
—
0
0
263
2350
1.99
3.74
39.0
15.2
4.0
4.0
mmol/l
3.01
258
2278
80
534
1.68
3.64
1.9
1.7
0.8
1.3
mg/l
1.75
62
413
262
2345
1.95
3.61
38.3
15.1
139.6
139.7
mmol/l
0.22
257
2274
17
63
2.80
3.55
1.8
1.4
—
—
—
0
0
63
402
1.72
3.37
4.8
3.0
2.5
2.4
mmol/l
0.63
52
357
116
867
1.55
3.27
4.9
3.8
48.7
45.1
ng/l
0.10
86
599
204
1737
1.55
3.07
5.6
3.7
15.6
11.2
mm/h
2.66
194
1597
13
45
2.97
3.06
1.5
1.3
—
—
—
0
0
201
1720
1.51
2.84
4.0
3.8
14.6
14.7
pmol/l
0.22
183
1568
6
11
5.54
2.55
2.7
3.7
—
—
—
0
0
6
11
5.54
2.55
2.7
3.7
—
—
—
0
0
44
275
1.70
2.53
29.4
24.3
1.0
1.4
inr
—
7
34
84
620
1.49
2.41
3.9
3.1
3270.1
1402.9
ng/l
0.93
73
523
5
9
5.63
2.22
1.0
1.6
—
—
—
0
0
5
9
5.63
2.22
1.0
1.6
—
—
—
0
0
12
49
2.51
2.13
1.8
1.4
—
—
—
0
0
8
25
3.26
2.11
1.6
1.2
—
—
—
0
0
7
22
3.23
1.89
1.0
1.5
—
—
—
0
0
11
46
2.44
1.87
2.7
1.3
—
—
—
0
0
11
46
2.44
1.87
2.7
1.3
—
—
—
0
0
22
124
1.84
1.81
1.9
1.8
—
—
—
0
0
54
387
1.48
1.77
1.1
1.3
18.0
9.1
u/ml
0.21
19
158
6
18
3.38
1.75
1.7
1.6
—
—
—
0
0
241
2218
1.45
1.75
4.5
3.8
1.4
1.3
mmol/l
0.96
226
2036
251
2328
1.49
1.74
5.4
4.5
2.6
2.8
mmol/l
1.82
239
2147
11
49
2.29
1.65
2.0
1.4
—
—
—
0
0
16
85
1.93
1.58
1.4
2.3
—
—
—
0
0
13
64
2.08
1.56
1.8
1.4
—
—
—
0
0
67
513
1.39
1.55
1.2
1.3
0.5
1.6
u/ml
1.74
14
136
8
33
2.46
1.55
2.0
1.2
—
—
—
0
0
8
33
2.46
1.55
1.5
1.5
—
—
—
0
0
23
140
1.70
1.50
1.8
1.4
—
—
—
0
0
11
52
2.16
1.46
2.5
1.3
—
—
—
0
0
7
28
2.53
1.46
1.3
1.3
—
—
—
0
0
238
2212
1.37
1.40
5.0
4.2
5.8
5.9
mmol/l
0.24
224
2033
245
2288
1.39
1.40
5.1
4.2
4.4
4.6
mmol/l
2.20
234
2122
9
41
2.23
1.38
1.9
1.2
—
—
—
0
0
244
2279
1.38
1.37
5.0
4.1
1.4
1.4
mmol/l
2.88
232
2104
9
42
2.18
1.35
1.4
1.5
—
—
—
0
0
225
2080
1.33
1.32
7.2
5.3
39.4
39.6
mmol/mol
0.10
215
1945
53
401
1.39
1.32
1.2
1.3
81.0
35.1
iu/ml
0.37
13
125
59
455
1.37
1.31
1.6
1.6
—
—
—
0
0
6
24
2.53
1.31
1.2
1.4
—
—
—
0
0
235
2188
1.35
1.30
29.2
12.5
71.3
84.0
ml/min/173m2
8.29
195
1774
5
18
2.81
1.29
1.0
1.1
—
—
—
0
0
8
37
2.19
1.22
1.5
1.4
—
—
—
0
0
13
71
1.87
1.21
4.0
2.8
—
—
—
0
0
12
64
1.91
1.19
1.9
1.5
—
—
—
0
0
8
38
2.13
1.19
1.3
1.1
—
—
—
0
0
6
26
2.33
1.19
1.5
1.8
—
—
—
0
0
174
1569
1.26
1.17
3.5
3.3
—
—
—
0
0
39
288
1.41
1.12
3.0
2.7
11.8
8.3
umol/l
0.32
33
246
10
51
1.99
1.12
1.1
1.4
—
—
—
0
0
7
31
2.29
1.11
1.6
1.5
—
—
—
0
0
10
52
1.96
1.07
1.0
1.3
—
—
—
0
0
14
83
1.72
1.03
3.1
2.0
—
—
—
0
0
223
2086
1.27
1.02
5.2
4.5
1.8
1.9
mu/l
0.71
208
1903
5
23
2.19
0.98
2.4
1.1
—
—
—
0
0
229
2155
1.27
0.96
33.3
14.1
38.4
40.2
%
2.04
174
1641
6
27
2.25
0.94
1.2
1.1
—
—
—
0
0
9
52
1.75
0.93
1.8
1.4
—
—
—
0
0
6
28
2.17
0.92
1.0
1.2
—
—
nmol/l
—
0
0
6
29
2.09
0.90
1.5
1.8
—
—
—
0
0
69
582
1.24
0.81
1.8
1.6
1.4
1.4
mmol/l
0.01
61
490
15
98
1.56
0.80
1.9
1.9
—
—
—
0
0
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
5
25
2.02
0.73
3.0
3.2
—
—
—
0
0
7
40
1.77
0.71
1.9
1.4
—
—
—
0
0
19
135
1.44
0.71
3.3
3.5
4.5
4.6
pmol/l
0.17
19
118
95
839
1.19
0.71
5.4
5.0
4.1
2.8
ug/l
0.58
84
759
5
27
1.87
0.68
1.0
1.5
28.4
16.5
ug/l
—
5
27
5
28
1.80
0.66
12.2
17.4
1838.0
1501.9
nmol/l
—
5
28
12
79
1.54
0.63
1.6
2.4
0.1
0.8
g/l
1.40
12
73
8
51
1.58
0.61
1.1
1.2
—
—
—
0
0
12
80
1.52
0.60
2.8
1.7
—
—
—
0
0
0
21
0.00
0.60
0.0
3.4
—
71.6
—
0
21
10
146
0.67
0.53
1.4
1.7
—
—
—
0
0
9
63
1.44
0.53
1.0
1.4
—
—
—
0
0
170
1603
1.14
0.51
4.2
2.9
43.7
45.9
u/l
0.21
162
1513
7
48
1.47
0.47
1.7
1.7
—
—
—
0
0
11
78
1.43
0.43
1.4
1.2
—
—
—
0
0
11
79
1.41
0.41
1.4
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
9
66
1.37
0.38
1.0
1.1
—
—
—
0
0
75
685
1.13
0.36
5.4
4.3
23.7
21.3
%
0.60
42
315
14
177
0.78
0.34
1.4
1.9
—
—
—
0
0
19
156
1.23
0.32
1.2
1.3
—
32.6
—
0
11
33
296
1.13
0.22
1.8
2.0
—
—
—
0
0
5
41
1.22
0.22
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
63.6
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
8.8
—
0
10
0
12
0.00
0.21
0.0
2.7
—
52.4
—
0
12
25
221
1.14
0.21
2.8
4.1
3.4
9.9
ug/l
1.78
20
181
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
473.3
—
0
8
0
14
0.00
0.20
0.0
1.0
—
36.8
—
0
8
23
258
0.88
0.18
25.8
7.4
—
—
—
0
0
7
59
1.19
0.18
1.9
1.5
—
—
—
0
0
5
70
0.71
0.17
1.8
1.4
—
—
—
0
0
8
69
1.16
0.16
1.7
1.7
—
—
—
0
0
35
325
1.09
0.14
1.8
2.1
—
—
—
0
0
28
262
1.08
0.09
4.2
4.1
33.7
31.1
%
0.70
23
164
5
48
1.04
0.09
1.2
1.6
—
—
—
0
0
34
359
0.94
0.09
1.6
1.5
—
—
—
0
0
10
113
0.88
0.08
1.3
1.0
—
—
—
0
0
53
510
1.05
0.08
3.6
3.1
1.6
0.8
ug/l
0.47
39
338
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
8
74
1.08
0.07
1.8
1.5
—
—
—
0
0
8
78
1.03
0.07
1.9
1.6
—
—
—
0
0
18
170
1.06
0.04
1.2
1.2
177.2
148.8
iu/ml
—
10
66
24
250
0.96
0.03
1.4
1.7
—
—
—
0
0
13
131
0.99
0.00
1.7
1.5
—
—
—
0
0
14
137
1.02
0.00
1.3
1.3
—
—
—
0
0
7
76
0.92
0.00
1.7
1.4
—
—
—
0
0
6
64
0.94
0.00
1.5
1.7
196.7
225.4
pmol/l
—
6
58
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_RECURANDPERHEAMATUR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_RECURANDPERHEAMATUR | 2.32 [1.83, 2.94] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.11 |
During the follow-up period (1.1.1998 — 31.12.2019), 187 out of 1005 females with N14_RECURANDPERHEAMATUR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| N14_RECURANDPERHEAMATUR | 2.256 [1.73, 2.94] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 422 out of 1118 males with N14_RECURANDPERHEAMATUR died.
Mortality risk
Mortality risk for people of age
years, who have N14_RECURANDPERHEAMATUR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.215% | 0.347% |
| 5 | 1.295% | 2.358% |
| 10 | 3.217% | 5.811% |
| 15 | 5.868% | 11.113% |
| 20 | 10.82% | 18.533% |
Relationships between endpoints
↥Index endpoint: N14_RECURANDPERHEAMATUR – Recurrent and persistent haematuria
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data